Acclaromd
Founded 2018 · 127 employees on LinkedIn · 1 known investors
Acclaro develops UltraClear, an aesthetic laser platform using proprietary 2910 nm cold ablative fiber laser technology with seven treatment modules in one device for skin rejuvenation, addressing photodamage, wrinkles, acne scars, pigmentation, and laser-enabled surgical procedures. The device is sold to physicians and aesthetic practices for treating patients across all skin types.
Investors · 1
Frequently asked questions
- What does Acclaromd do?
- Acclaro develops UltraClear, an aesthetic laser platform using proprietary 2910 nm cold ablative fiber laser technology with seven treatment modules in one device for skin rejuvenation, addressing photodamage, wrinkles, acne scars, pigmentation, and laser-enabled surgical procedures. The device is sold to physicians and aesthetic practices for treating patients across all skin types.
- Who are Acclaromd's investors?
- Acclaromd's investors include Accelmed Partners.